GPAT4
Basic information
Region (hg38): 8:41577186-41625001
Previous symbols: [ "AGPAT6" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn genetic diseases (8 variants)
- not provided (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GPAT4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 8 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region ? | 1 | 1 | ||||
non coding ? | 0 | |||||
Total | 0 | 0 | 8 | 0 | 1 |
Variants in GPAT4
This is a list of pathogenic ClinVar variants found in the GPAT4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
8-41599266-C-G | not specified | Uncertain significance (Sep 13, 2023) | ||
8-41609432-T-C | not specified | Uncertain significance (Apr 26, 2023) | ||
8-41609438-G-A | not specified | Uncertain significance (Nov 08, 2022) | ||
8-41609457-C-A | not specified | Uncertain significance (Aug 17, 2021) | ||
8-41609665-A-G | Benign (Aug 01, 2018) | |||
8-41609697-A-G | not specified | Uncertain significance (Dec 17, 2023) | ||
8-41611928-G-A | not specified | Uncertain significance (Sep 26, 2022) | ||
8-41611979-A-G | not specified | Uncertain significance (Nov 22, 2023) | ||
8-41612000-C-T | Benign (Nov 15, 2017) | |||
8-41612888-C-T | not specified | Uncertain significance (Jan 03, 2024) | ||
8-41612911-G-A | not specified | Uncertain significance (Jul 25, 2023) | ||
8-41612927-C-T | not specified | Uncertain significance (Nov 09, 2023) | ||
8-41618751-G-A | not specified | Uncertain significance (Dec 14, 2021) | ||
8-41618802-T-A | not specified | Uncertain significance (Jan 26, 2022) | ||
8-41620897-G-T | not specified | Uncertain significance (Dec 18, 2023) | ||
8-41620928-C-T | not specified | Uncertain significance (Dec 01, 2022) | ||
8-41620981-A-G | not specified | Likely benign (Nov 20, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GPAT4 | protein_coding | protein_coding | ENST00000396987 | 12 | 47815 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0881 | 0.912 | 125738 | 0 | 10 | 125748 | 0.0000398 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.70 | 140 | 263 | 0.531 | 0.0000144 | 2996 |
Missense in Polyphen | 35 | 77.196 | 0.45339 | 838 | ||
Synonymous | 0.0446 | 100 | 101 | 0.994 | 0.00000583 | 872 |
Loss of Function | 3.47 | 7 | 26.2 | 0.268 | 0.00000135 | 293 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000579 | 0.0000579 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000352 | 0.0000352 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.0000655 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Esterifies acyl-group from acyl-ACP to the sn-1 position of glycerol-3-phosphate, an essential step in glycerolipid biosynthesis. Active against both saturated and unsaturated long- chain fatty acyl-CoAs. {ECO:0000269|PubMed:18238778}.;
- Pathway
- Glycerolipid metabolism - Homo sapiens (human);Glycerophospholipid metabolism - Homo sapiens (human);Metabolism of lipids;Metabolism;CDP-diacylglycerol biosynthesis;Glycerophospholipid metabolism;triacylglycerol biosynthesis;Glycerophospholipid biosynthesis;Phospholipid metabolism;Synthesis of PA
(Consensus)
Recessive Scores
- pRec
- 0.133
Intolerance Scores
- loftool
- rvis_EVS
- -0.41
- rvis_percentile_EVS
- 26.23
Haploinsufficiency Scores
- pHI
- 0.178
- hipred
- Y
- hipred_score
- 0.707
- ghis
- 0.598
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Mouse Genome Informatics
- Gene name
- Gpat4
- Phenotype
- endocrine/exocrine gland phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- glandular epithelial cell maturation;fatty acid metabolic process;acyl-CoA metabolic process;phosphatidic acid biosynthetic process;phosphatidylcholine biosynthetic process;lactation;lipid biosynthetic process;CDP-diacylglycerol biosynthetic process;triglyceride biosynthetic process;regulation of multicellular organism growth;diacylglycerol metabolic process
- Cellular component
- endoplasmic reticulum;endoplasmic reticulum membrane;membrane;integral component of membrane
- Molecular function
- 1-acylglycerol-3-phosphate O-acyltransferase activity;glycerol-3-phosphate O-acyltransferase activity;sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity